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Case Report
Abstract
Objective: There have been few reports of priapism as complications of various       haematological 
malignancies. Delays in establishing the cause and late institution of appropriate intervention in patients 
suffering from priapism could result in long-term complications, especially erectile dysfunction. We 
present here a case of chronic myeloid leukaemia (CML) in a 30 year old male who presented with 
priapism as the only symptom. Apart from presenting this as a rare case report, it also emphasizes the need 
for early full blood count in patients presenting with priapism.
Methods: The case note of the patient, as well as all available literature on the subject were reviewed.
Results: The 30 year old man who presented with a 9 (nine) day history of persistent painful non-sexually 
related penile erection was found to have chronic myeloid leukaemia (CML) following peripheral and 
bone marrow aspiration studies. He however had a delay in referral and diagnosis of his primary condition 
and eventually had erectile dysfunction. The priapism responded well to surgical intervention and use of 
cyto-reductive therapy. The erectile dysfunction could have been averted if complete blood count and, or 
peripheral blood film were carried out at the time of first  presentation 
Conclusion: Priapism due to hyperviscosity can be the first presentation in patients with Chronic Myeloid 
Leukaemia, and CML should therefore always be considered in a patient with priapism.  High Index of 
Suspicion, as well as early full blood count and peripheral blood/Bone marrow examination among 
patients presenting with priapism will facilitate prompt and correct diagnosis, and reduce, if not prevent 
erectile dysfunction and other severe complications that may arise from priapism.
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La leucémie myéloïde chronique présentant priapisme comme le seul 
symptôme: Un rapport de cas et revue de la littérature.
1 1 2 3
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Rapport de cas
Resume
Objectif: Il y a eu quelques rapports de priapisme comme complications de diverses hémopathies 
malignes. Les retards dans l'établissement de la cause et de l'institution tardive d'une intervention 
appropriée chez les patients souffrant de priapisme pourraient entraîner des complications à long terme, en 
particulier la dysfonction érectile. Nous présentons ici un cas de leucémie myéloïde chronique (LMC) 
chez un homme de 30 ans qui a présenté avec priapisme comme le seul symptôme. En dehors de la 
présentation de ce qu'un rapport de rares cas, il souligne également la nécessité d'une numération formule 
sanguine précoce chez les patients présentant un priapisme.
Méthodes: La note de cas du patient, ainsi que toute la littérature disponible sur le sujet ont été examinées.
Résultats: Le vieil homme de 30 ans qui a présenté avec une histoire 9 (neuf) de jour de la persistance 
douloureuse érection du pénis non liées sexuellement a été constaté que la leucémie myéloïde chronique 
(LMC) suite à des études d'aspiration de la moelle osseuse et de périphériques. Il a cependant eu un retard 
dans l'orientation et le diagnostic de son état primaire et a finalement dû dysfonction érectile. Le priapisme 
a bien réagi à l'intervention et l'utilisation de la thérapie cyto-réductrice chirurgicale. La dysfonction 
érectile aurait pu être évitée si la numération globulaire complète et, ou d'un film de sang périphérique ont 
été réalisées au moment de la première présentation
Conclusion: Priapisme en raison de l'hyperviscosité peut être la première présentation chez les patients 
atteints de leucémie myéloïde chronique, et la LMC doit donc toujours être considéré dans un patient avec 
priapisme. Haut Indice de suspicion, ainsi que tôt hémogramme et du sang périphérique / os examen de la 
moelle chez les patients présentant un priapisme facilitera un diagnostic rapide et correct, et de réduire, 
voire prévenir la dysfonction érectile et d'autres complications graves qui peuvent résulter de priapisme.
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INTRODUCTION
Priapism is a urological emergency that 
requires urgent intervention to prevent erectile 
dysfunction(1). It is defined as persistent, painful, 
penile erection not related to sexual stimulation. 
It is classified into high-flow (non-ischaemic) 
and low-flow (ischaemic) types(2). Low-flow 
priapism results from reduced penile venous 
drainage, while high-flow priapism results from 
increased carvenosal arterial inflow.
Priapism is a rare medical condition with a 
worldwide incidence of 1.5 per 100,000 persons 
per annum(3). Most cases (64%) of priapism are 
idiopathic while about 20% are caused by 
h a e m a t o l o g i c a l  d i s o r d e r s .  A l t h o u g h  
haematological conditions are the major cause of 
ischaemic priapism, it is however rare in 
leukaemias. It is important therefore to evaluate 
all cases of priapism for leukaemias in order to 
facilitate early diagnosis, allow prompt 
institution of appropriate interventions, and 
avoid potential complications.
We report here a 30 year old, Nigerian 
male, who presented to the emergency 
department with nine days history of persistent, 
painful, penile erection. Investigations revealed 
that he had chronic myeloid leukaemia which was 
missed in two different health facilities 9 days 
prior to presentation to our facility.
Case presentation
A 30 year old Nigerian man of the Tiv 
tribe presented to our emergency department with 
9 days history of persistent, painful, penile 
erection which he noticed on waking up from 
sleep. He had a stuttering episode a month prior to 
presentation. His last sexual activity was about 2 
weeks prior to the onset of the symptom. He had 
no antecedent trauma to the penile area and no 
history of using sex enhancing drugs. He was not 
a known sickle cell disease patient. There were 
associated recurrent bone pains which started a 
year ago with occasional yellowness of the eyes. 
There was no history of gum bleeding, bleeding 
from any orifices, or into the skin but he 
complained of prolonged bleeding after minor 
cuts of one year duration. There was no fever, 
weakness, or cough. 
He had been to two other hospitals prior to 
presentation. In the last hospital before ours, he 
had aspiration and irrigation without achieving 
sustained detumesence. 
On examination, he was in painful distress, his 
pulse rate was 96 beats per minute, blood 
pressure was 130/80 mmHg. Chest was clinically 
clear. Abdominal examination revealed an 
enlarged, non-tender spleen of 10cm below the 
left costal margin. The liver and kidneys were not 
palpably enlarged. Penile examination showed an 
erect, edematous penis with hard shaft and soft 
glans and multiple blot clots at the puncture sites 
for aspiration. The superficial penile veins were 
engorged. (Fig.I)
Complete blood count showed moderate 
anaemia of 9.2g/dl, mild thrombocytopaenia of 
986x10 /l, and marked neutrophil leukocytosis of 
9261x10 /l with neutrophil differential of 96%. On 
p e r i p h e r a l  b l o o d  f i l m  e x a m i n a t i o n ,  
anisopoikilocytosis, polychromasia, and 
nucleated red cells were noted. The granulocytes 
were markedly elevated with complete spectrum 
of the maturing myeloid cells present. There were 
elevated numbers of basophils and eosinophils. 
The Urea and uric acid were mildly elevated but 
creatinine was normal. Liver function test was 
normal. Bone marrow aspiration morphology 
showed myeloid hyperplasia consistent with 
chronic myeloid leukaemia.
Cytogenetic studies for BCR-ABL1 fusion gene 
and cavernosal blood gas analyses were not done 
due to lack of facilities.
Following the result of these investigations, the 
diagnosis of chronic phase CML with low flow 
priapism was made. 
T he patient was commenced on hydration 
with 0.9% normal saline to alternate with 5% 
dextrose water. He had aspiration of the corpora 
cavernosa and irrigation with epinephrine and 
achieved detumescence which was not sustained. 
Allopurinol 300mg daily and hydroxyurea 2g 
daily were commenced immediately. He had 
bilateral T-shunts after the commencement of 
hydroxyurea and achieved detumescence which 
was sustained.(Fig.II) 
On day 16, his neutrophil count dropped to 
9
99.2x10 /l, his haemoglobin and platelets 
9
appreciated to 10.7g/dl and 317x10 /l 
respectively. He was discharged on 1g 
hydroxyurea daily. He was advised on the need to 
carry out cytogenetics analysis for Philadelphia 
chromosome. We plan to refer him to a centre 
where he can assess tyrosine kinase inhibitor if 
the result of this investigation is positive. 
Follow up
The patient reported to us a month after 
discharge and complained of inability to achieve 
strong erection. 
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DISCUSSSION 
Priapism is a condition that is 
characterized by unwanted and sustained 
erection that does not result from sexual desire 
and not relieved by sexual activity(4).  It has a 
bimodal distribution of age of onset with peaks at 
5-13 years of age and 21-29 years of age(5). In 
this case our patient presented at age of 30 years 
which is around the second peak age of onset. It is 
a surgical emergency because it is a form of 
compartment syndrome and therefore it is a 
serious medical condition that can affect 
sexuality and reproductive life in those 
affected(6).
Priapism results from either increased 
arterial inflow (high-flow) or, more commonly, 
from the failure of venous out flow (low-flow or 
ischaemic type), resulting in the trapping of blood 
within the erectile tissues of the penis(7, 8, 9). 
Our patient's priapism is most likely the low-flow 
or ischaemic type because of the finding of 
hyperleucocytosis, engorged penile superficial 
veins, and turgid penile shaft with soft glans 
which are the typical findings in low- flow, 
ischaemic priapism. Intracavernosal blood gas 
analysis would have been helpful in 
distinguishing these types but we do not have the 
facility to carry it out. In high-flow priapism, the 
intracavernosal blood gas analysis is normal but 
in low-flow priapism the intracavernosal blood 
pH is less than 7.00, the partial pressure of carbon 
dioxide (PCO2) more than 60 mmHg, and partial 
pressure of oxygen (PO2) is less than 30 
mmHg(10, 11).
Priapism is uncommon in the general 
population but it has been recognized as a serious 
complication of sickle cell disease(12).  It occurs 
in about 40% of men with sickle cell 
anaemia(13).  Less common causes of priapism 
are trauma to the penis, leukemia, cancerous 
invasion of the penis, drugs, alcoholic ingestion, 
various thromboembolic disease,  and 
intravenous fat for parenteral nutrition(14).
Chronic myeloid leukaemia (CML) is a clonal 
disease that results from an acquired genetic 
change in a pluripotential haemopoietic stem cell. 
This change leads to the proliferation of the cell 
and the accumulation of a population of cells that 
gradually displaces normal haemopoiesis. The 
end result is a greatly expanded total myeloid 
mass(15).
Cytogenetically, CML results from a 
reciprocal translocation of chromosomal 
materials between the long arms of chromosome 
9 and chromosome 22, [t(9;22)(q14;q11)]. This 
translocation leads to the generation of the fusion 
gene BCR-ABL1 and subsequently formation of 
a fusion protein with increased tyrosine kinase 
activity.
CML presents majorly with features of 
hyper metabolism, splenomegaly, and features of 
bone marrow failure. Savage et al  (16) reported 
that Fatigue or lethargy was the most common 
symptom of CML followed by bleeding, weight 
loss, and complaints attributable to splenic 
enlargement. Our patient did not present with 
these common symptoms but admitted to a year 
history of prolonged bleeding following injuries 
which he did not consider serious enough to 
require medical attention. If he had presented a 
year earlier, when he first noticed the abnormal 
bleeding, his diagnosis would have been 
established and treatment commenced. 
Symptoms of leucostasis including priapism 
have been noted to be rare and unusual in 
CML(14, 16).  It has been suggested that the low 
incidence of leucostasis in CML was probably 
related to the inverse correlation between the 
WBC and haemoglobin concentration, which 
tends to prevent a marked rise in whole blood 
viscosity(17-20)
Many mechanisms for the development 
of priapism in CML patients have been postulated 
but cardinal among them is hyperleucocytosis, 
which is described as white cell counts in the 
9excess of 100 cells x10 /l. Our patient had a total 
9WBC count of 261x10 /l at presentation. The 
different pathophysiologic mechanisms for 
priapism in CML are sludging of leukemic cells 
in the corpora cavernosa and the dorsal veins of 
penis, venous congestion of the corpora 
cavernosa from mechanical pressure on the 
abdominal veins by the splenomegaly and 
infiltration of the central nerve.
Management of priapism depends on 
whether it is high or low-flow. Leukaemic 
priapism is usually ischaemic (low-flow) and 
therefore a urological emergency requiring 
urgent  intervention.  Our pat ient  had 
hyperleucocytosis and features consistent with 
low-flow. Because leukaemic priapism is a 
relatively rare occurrence, there is no standard 
treatment recommended for it. However, it is 
strongly recommended by the American 
Urological Association that systemic treatment of 
an underlying disorder, such as CML, should not 
be undertaken as the only treatment for ischaemic 
priapism(21). Intracavernous treatment is 
required, and should be administered 
concurrently. The index patient had aspiration of 
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the corpora cavernosa and irrigation with 
epinephrine and achieved detumescence which 
was not sustained. Allopurinol 300mg daily and 
hydroxyurea 2g daily were commenced 
immediately to ensure cytoreduction.  
Cytoreduction could also be achieved by carrying 
out leucopharesis, but we are yet to commence 
this procedure due to lack of facility. 
He had bilateral T-shunts and achieved 
detumescence which was sustained. This 
strongly supported the recommendation made 
above concerning combining the treatment for 
the  pr imary cause of  pr iapism with  
intracavernosal intervention. T shunt is a form 
cavernoglanular shunt, other cavernoglanular 
shunts include the Ebbehoj, Winter and Al-Gorab 
shunts. These are distal shunts. Other forms of 
treatment for priapism include proximal shunts 
such as the Quackles and caverno-venous shunts.
On follow up patient complained of inability to 
achieve erection for sexual activity. This is 
usually a complication of delay in achieving 
detumensence within 24-48 hours of  
development of priapism. Our patient had 
priapism for 9 days.
We are reporting this case to underscore, 
and emphasize the value of simple and 
inexpensive laboratory investigations (complete 
blood count and peripheral blood film) in the 
diagnosis and management of patients with 
priapism.
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Figure I: Penis prior to bilateral T-shunts and commencement of cytoreductive therapy 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II: Penis immediately after bilateral T-shunts 
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